Found: 81
Select item for more details and to access through your institution.
Transforming the nutrition care model for infants with cystic fibrosis: A qualitative study of clinicians' perspectives.
- Published in:
- Pediatric Pulmonology, 2023, v. 58, n. 5, p. 1380, doi. 10.1002/ppul.26330
- By:
- Publication type:
- Article
Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations.
- Published in:
- Annals of the American Thoracic Society, 2023, v. 20, n. 1, p. 75, doi. 10.1513/AnnalsATS.202203-201OC
- By:
- Publication type:
- Article
Longitudinal Assessment of Pseudomonas aeruginosa in Young Children with Cystic Fibrosis.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 3, p. 444, doi. 10.1086/318075
- By:
- Publication type:
- Article
Effect of Chronic Intermittent Administration of Inhaled Tobramycin on Respiratory Microbial Flora in Patients with Cystic Fibrosis.
- Published in:
- Journal of Infectious Diseases, 1999, v. 179, n. 5, p. 1190, doi. 10.1086/314727
- By:
- Publication type:
- Article
Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infection.
- Published in:
- BMC Microbiology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12866-023-03073-8
- By:
- Publication type:
- Article
Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study.
- Published in:
- Pediatric Pulmonology, 2019, v. 54, n. 5, p. 581, doi. 10.1002/ppul.24261
- By:
- Publication type:
- Article
Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.
- Published in:
- Pediatric Pulmonology, 2015, v. 50, p. S3, doi. 10.1002/ppul.23240
- By:
- Publication type:
- Article
Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2013, v. 48, n. 10, p. 943, doi. 10.1002/ppul.22693
- By:
- Publication type:
- Article
Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2012, v. 47, n. 2, p. 125, doi. 10.1002/ppul.21525
- By:
- Publication type:
- Article
Baseline Characteristics and Factors Associated With Nutritional and Pulmonary Status at Enrollment in the Cystic Fibrosis EPIC Observational Cohort.
- Published in:
- Pediatric Pulmonology, 2010, v. 45, n. 9, p. 934, doi. 10.1002/ppul.21279
- By:
- Publication type:
- Article
Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2007, v. 42, n. 9, p. 751, doi. 10.1002/ppul.20665
- By:
- Publication type:
- Article
Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2007, v. 42, n. 7, p. 610, doi. 10.1002/ppul.20625
- By:
- Publication type:
- Article
Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: Results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2005, v. 39, n. 4, p. 339
- By:
- Publication type:
- Article
Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study of Aerosolized Interferon Gamma-1b in Patients With Mild to Moderate Cystic Fibrosis Lung DiseaseOur results were presented in part at the American Thoracic Society 2003 Annual Meeting (Moss et al., Am J Respir Crit Care Med 2003;167:923).Conflict of interest statement: Karen Starko, M.D., is an employee of Intermune, Inc., which partly sponsored this study, provided study agents, and participated in data analysis.
- Published in:
- Pediatric Pulmonology, 2005, v. 39, n. 3, p. 209, doi. 10.1002/ppul.20152
- By:
- Publication type:
- Article
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2002, v. 34, n. 2, p. 91, doi. 10.1002/ppul.10127
- By:
- Publication type:
- Article
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2001, v. 32, n. 5, p. 356, doi. 10.1002/ppul.1144
- By:
- Publication type:
- Article
Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: Results of a phase I multi-center study.
- Published in:
- Pediatric Pulmonology, 2001, v. 32, n. 2, p. 122, doi. 10.1002/ppul.1098
- By:
- Publication type:
- Article
Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 1999, v. 28, n. 5, p. 321, doi. 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V
- By:
- Publication type:
- Article
Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis.
- Published in:
- Scientific Reports, 2016, p. 22493, doi. 10.1038/srep22493
- By:
- Publication type:
- Article
Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients.
- Published in:
- Molecular Microbiology, 2007, v. 64, n. 2, p. 512, doi. 10.1111/j.1365-2958.2007.05678.x
- By:
- Publication type:
- Article
Unique Lipid A Modifications in Pseudomonas aeruginosa Isolated from the Airways of Patients with Cystic Fibrosis.
- Published in:
- Journal of Infectious Diseases, 2007, v. 196, n. 7, p. 1088, doi. 10.1086/521367
- By:
- Publication type:
- Article
Disposition of drugs in cystic fibrosis. VI. In vivo activity of cytochrome P450 isoforms involved in the metabolism of (R)-warfarin (including P450 3A4) is not enhanced in cystic fibrosis.
- Published in:
- Clinical Pharmacology & Therapeutics, 1994, v. 55, n. 5, p. 528, doi. 10.1038/clpt.1994.66
- By:
- Publication type:
- Article
Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin.
- Published in:
- Clinical Pharmacology & Therapeutics, 1993, v. 54, n. 3, p. 293, doi. 10.1038/clpt.1993.150
- By:
- Publication type:
- Article
Disposition of drugs in cystic fibrosis. I. Sulfamethoxazole and trimethoprim.
- Published in:
- Clinical Pharmacology & Therapeutics, 1991, v. 49, n. 4, p. 402, doi. 10.1038/clpt.1991.47
- By:
- Publication type:
- Article
Pharmacokinetics of ticarcillin in patients with cystic fibrosis: A controlled prospective study.
- Published in:
- Clinical Pharmacology & Therapeutics, 1990, v. 47, n. 1, p. 73, doi. 10.1038/clpt.1990.11
- By:
- Publication type:
- Article
Elexacaftor/Tezacaftor/Ivacaftor Treatment and Depression-related Events.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 3, p. 299, doi. 10.1164/rccm.202308-1525OC
- By:
- Publication type:
- Article
Phoenix from the Ashes: Celebrating the 2023 North American Cystic Fibrosis Conference.
- Published in:
- 2023
- By:
- Publication type:
- Proceeding
Cystic Fibrosis: From Tragedy to Triumph.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 1, p. 9, doi. 10.1164/rccm.202305-0785ED
- By:
- Publication type:
- Article
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 1, p. 59, doi. 10.1164/rccm.202301-0084OC
- By:
- Publication type:
- Article
Cystic Fibrosis: A Disease in Transformation, yet More Work to Be Done!
- Published in:
- 2022
- By:
- Publication type:
- Editorial
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One Allele.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Not Quite the Bully in the Schoolyard: Can Survive and Coexist with in the Cystic Fibrosis Lung.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Update in Cystic Fibrosis 2018.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reply to Shanthikumar et al.: Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis: Do the Benefits Outweigh the Harms?
- Published in:
- 2018
- By:
- Publication type:
- Letter
Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results.
- Published in:
- 2017
- By:
- Publication type:
- journal article
AJRCCM: 100-Year Anniversary. Progress along the Pathway of Discovery Leading to Treatment and Cure of Cystic Fibrosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Progress along the Pathway of Discovery Leading to Treatment and Cure of Cystic Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2017, v. 195, n. 9, p. 1092, doi. 10.1164/rccm.201702-0266ed
- By:
- Publication type:
- Article
Update in Cystic Fibrosis 2014.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Effect of nebulizer type and antibiotic concentration on device performance.
- Published in:
- Pediatric Pulmonology, 1997, v. 23, n. 4, p. 249, doi. 10.1002/(SICI)1099-0496(199704)23:4<249::AID-PPUL2>3.0.CO;2-H
- By:
- Publication type:
- Article
What is the role of upper airway bacterial cultures in patients with cystic fibrosis?
- Published in:
- Pediatric Pulmonology, 1996, v. 21, n. 5, p. 265, doi. 10.1002/1099-0496(199605)21:5<265::AID-PPUL1950210502>3.0.CO;2-5
- By:
- Publication type:
- Article
Aerosol administration of antibiotics.
- Published in:
- Pediatric Pulmonology, 1995, v. 19, n. S11, p. 68, doi. 10.1002/ppul.1950191135
- By:
- Publication type:
- Article
Consensus conference: Practical applications of pulmozyme® september 22, 1993.
- Published in:
- Pediatric Pulmonology, 1994, v. 17, n. 6, p. 404, doi. 10.1002/ppul.1950170613
- By:
- Publication type:
- Article
Nebulizer delivery of tobramycin to the lower respiratory tract.
- Published in:
- Pediatric Pulmonology, 1994, v. 17, n. 5, p. 331, doi. 10.1002/ppul.1950170511
- By:
- Publication type:
- Article
Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 1989, v. 7, n. 4, p. 265, doi. 10.1002/ppul.1950070413
- By:
- Publication type:
- Article
The Northwest Participant and Clinical Interactions Network: Increasing opportunities for patients to participate in research across the Northwestern United States.
- Published in:
- Journal of Clinical & Translational Science, 2017, v. 1, n. 2, p. 94, doi. 10.1017/cts.2016.18
- By:
- Publication type:
- Article
Antenatal Screening for CFTR Variants—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 14, p. 1388, doi. 10.1001/jama.2023.14994
- By:
- Publication type:
- Article
Cystic Fibrosis: A Review.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 21, p. 1859, doi. 10.1001/jama.2023.8120
- By:
- Publication type:
- Article
Highly Effective Cystic Fibrosis Clinical Research Teams: Critical Success Factors.
- Published in:
- JGIM: Journal of General Internal Medicine, 2014, v. 29, p. 714, doi. 10.1007/s11606-014-2896-8
- By:
- Publication type:
- Article
No Detectable Improvements in Cystic Fibrosis Transmembrane Conductance Regulator by Nasal Aminoglycosides in Patients with Cystic Fibrosis with Stop Mutations.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2007, v. 37, n. 1, p. 57, doi. 10.1165/rcmb.2006-0173OC
- By:
- Publication type:
- Article